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Introduction
The electrothermal vessel sealing system facilitates operative
haemostasis by applying controlled electrothermal energy
to blood vessel walls, resulting in a fused collagen seal.1 The
LigaSure™ (ValleyLab Corp, a division of Tyco Healthcare
Group LP, Boulder, CO, USA) is the most widely used
electrothermal vessel sealing device. There have been several
reports in the past few years describing the use of the LigaSure™
in a variety of gastrointestinal, gynaecological and urological
operations.2–6 The LigaSure™ is used to achieve haemostasis
of blood vessels encountered during dissection, and can also
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be used to divide certain vascularized tissues such as the
mesentery and omentum. Several studies have demonstrated
a reduction in operating time when the LigaSure™ is used.1–4
The risk of bleeding does not appear to increase with LigaSure™
use, and some reports have even shown reduced operative
blood loss.2,3 The LigaSure™ also has a reduced energy spread
profile (< 2 mm) when compared with unipolar cautery, with
a potential decreased risk of injury to adjacent structures.
However, it is not applicable to all operative procedures. For
example, one study demonstrated that the LigaSure™ alone
was not effective for transecting the cystic duct during
cholecystectomy.3
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gynaecological and urological operations. We report our experience with LigaSure™ for thyroidectomy to test the
hypothesis that it reduces operating time without increasing complications compared with standard vessel
ligation.
METHODS: This non-randomized, retrospective review included 234 consecutive patients who underwent
thyroidectomy by one surgeon. Standard vessel ligation was used in 99 patients between 1997 and 2000, and the
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demographics, thyroid pathology, type of operation (total thyroidectomy vs lobectomy), operating time, com-
plications (transient or permanent hypocalcaemia, ) 8 mg/dL), recurrent or superior laryngeal nerve injury, neck
haematoma, wound complications, prolonged intubation), incision length and hospital stay.
RESULTS: The two groups had similar demographics, thyroid pathology, types of operations and complication
rates. The LigaSure™ group had lower operating times and incision lengths.
CONCLUSION: We found that the LigaSure™ was as safe as standard vessel ligation for thyroidectomy, with the
benefit of reduced operating time. A future prospective study has been designed. [Asian J Surg 2005;28(2):86–9]
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Some authors have recently reported their experience
with the use of new devices to facilitate haemostasis during
thyroid surgery. Two of these reports describe the use of
the harmonic scalpel in thyroidectomy.7,8 With numerous
institutions beginning to perform minimally invasive or
videoscopic thyroidectomy, there is an increased interest in
devices or techniques that reduce the need for conventional
knot-tying or suture ligation for haemostasis. At the Univer-
sity of California, San Francisco (UCSF), we have used the
LigaSure™ for haemostasis during thyroidectomy for the
past 3 years. In this paper, we present our experience with the
LigaSure™ in thyroidectomy and compare it with our previ-
ous experience with standard vessel ligation using ties and
suture ligatures. We hypothesized that use of the LigaSure™
would reduce operating time while resulting in a similar rate
of complications.
Patients and methods
We reviewed the medical records of 234 consecutive patients
who underwent thyroidectomy by one surgeon (QYD) at UCSF
between January 1997 and January 2003. The main outcome
measures included patient demographics, thyroid pathology,
type of operation performed (total thyroidectomy vs
lobectomy), operating time (recorded by the circulating nurse
as the time from skin incision to the application of the wound
dressing), complications, incision length and hospital stay.
The complications recorded included transient or permanent
hypocalcaemia (defined as serum calcium ) 8 mg/dL), tran-
sient or permanent recurrent or superior laryngeal nerve in-
jury, neck haematoma, wound complications and prolonged
intubation. We excluded patients undergoing re-operation,
including completion thyroidectomy, as well as those under-
going concomitant operations outside the neck.
During the first 4 years of this study period (January 1997–
December 2000), operative haemostasis was achieved using
standard vessel ligation with ties and suture ligatures. In
January 2001, we changed our operative technique and used
only the LigaSure™ electrothermal sealing system to achieve
haemostasis. Our current practice is to use the LigaSure™ on
all visible blood vessels, as well as on thyroid tissue when it
needs to be divided. When using the LigaSure™ on blood
vessels, it is our routine practice to place a single tie on the end
of the vessel that remains in the patient, without tying the end
that will be removed with the specimen. Thus, the LigaSure™
has reduced the number of vessel ties that we use by approxi-
mately 50%. In addition to reducing the number of ties, use of
the LigaSure™ has allowed us to change our operative strategy
for thyroidectomy. It is currently our routine practice to use
the LigaSure™ to divide the thyroid isthmus (provided there is
no evidence of cancer in the isthmus) at the beginning of each
thyroidectomy, for both total thyroidectomy and lobectomy.
We then retract the thyroid lobe medially using Allis clamps
and use the LigaSure™ on the lower and upper pole blood
vessels.
Patients who underwent thyroidectomy using standard
vessel ligation were compared with those who underwent
thyroidectomy using the LigaSure™. Statistical analysis was
performed using the t test and Chi-squared test, where
appropriate. Results are presented as mean ( standard error of
the mean, unless otherwise noted.
Results
Between 1 January 1997 and 31 December 2000, 99 patients
(20 men, 79 women) with an average age of 42.8 years under-
went thyroidectomy with standard vessel ligation. Between 1
January 2001 and 31 December 2002, 135 patients (27 men,
108 women) with an average age of 45.0 years underwent
thyroidectomy with the LigaSure™. There was no significant
difference in age (p > 0.05, t test) or in gender (p > 0.05, Chi-
squared test) between the two groups (Table 1).
The type of operation and thyroid pathologies did not
differ between the two groups (p > 0.05, Chi-squared test)
(Table 1). In the standard vessel ligation group, 37% under-
went thyroid lobectomy and 63% underwent total thyroid-
ectomy, while in the LigaSure™ group, 34% underwent
lobectomy and 66% underwent total thyroidectomy. The same
percentage of patients in both groups had benign thyroid
disease (73%) and thyroid cancer (27%). The number of pa-
tients with Graves’ disease was not significantly different
Table 1. Comparison of patients undergoing thyroidectomy by
standard vessel ligation or using the LigaSure™
Standard ligation LigaSure™
Patients, n 99 135
Gender 20 M, 79 F 27 M, 108 F
Age, yr 42.8 ( 1.6 45.0 ( 1.3
Lobectomy, n (%) 37 (37.4) 46 (34.1)
Total thyroidectomy, n (%) 62 (62.6) 89 (65.9)
Benign pathology, n (%) 72 (72.7) 98 (72.6)
Malignant pathology, n (%) 27 (27.3) 37 (27.4)
M = male; F = female.
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between the two groups (p > 0.05, Chi-squared test): seven
(7%) in the standard vessel ligation group and 16 (12%) in the
LigaSure™ group.
There was a significant reduction in operating time in the
LigaSure™ group (Table 2; 2.9 vs 3.6 hours; p < 0.05, t test).
We further divided the patients in each group by the type of
operation. The mean operating time for lobectomy in the
standard vessel ligation group (2.7 hours) was significantly
longer than that in the LigaSure™ group (2.2 hours; p < 0.05,
t test). A similar result was obtained for total thyroidectomy
(4.1 vs 3.2 hours; p < 0.05, t test). We also identified a reduction
in incision length for patients in the LigaSure™ group (Table
2; 5.7 vs 6.2; p < 0.05, t test).
There was no significant difference between the two groups
in the rates of transient or permanent complications (Table 3;
p > 0.05, Chi-squared test). In the standard vessel ligation
group, 15 transient complications included 11 cases of tran-
sient hypocalcaemia, two wound seromas, one case of tran-
sient hoarseness that resolved within 2 weeks and one pro-
longed intubation after removal of a large goitre. The two
permanent complications in this group were both recurrent
laryngeal nerve injuries. In one of these cases, there was thyroid
cancer invasion of the nerve necessitating nerve transection. In
the LigaSure™ group, 12 transient complications included
seven cases of transient hypocalcaemia, three cases of transient
hoarseness and two wound complications (1 seroma and 1
infection). The one permanent complication was a superior
laryngeal nerve injury.
It is our routine practice for patients to remain in the
hospital overnight following thyroidectomy. The mean hos-
pital stay was similar in the standard vessel ligation and
LigaSure™ groups (Table 3; p > 0.05, t test).
Discussion
Any modifications to established operative techniques for
thyroidectomy should result in similar or improved patient
outcomes and similar or lower rates of complications. In this
paper, we present our experience with the use of the LigaSure™,
an electrothermal vessel sealing system, in thyroidectomy. We
compared 99 patients who underwent thyroidectomy using
standard vessel ligation with 135 who underwent thyroid-
ectomy using the LigaSure™. The two groups had similar
demographics, thyroid pathology and rates of lobectomy ver-
sus total thyroidectomy. Mean operating time was reduced by
more than 30 minutes in the LigaSure™ group; for patients
undergoing lobectomy, there was a 30-minute reduction in
operating time, and for patients undergoing total thyroid-
ectomy, there was a nearly 1-hour reduction in operating
time. The mean incision length was reduced by 0.5 cm in the
LigaSure™ group. The rates of transient and permanent com-
plications were not significantly different between the two
groups. Mean hospital stay was also similar.
The reduction in operating time in the LigaSure™ group
was most probably a reflection of changes in operating
technique. The LigaSure™ allows us to reduce the number of
ties that we use for blood vessel ligation by approximately
50%. When dividing thyroid tissue, we no longer have to use
multiple suture ligatures and, instead, use the LigaSure™ for
this purpose. In addition, our strategy for thyroidectomy has
changed since we began using this device. We now routinely
begin each operation by using the LigaSure™ to divide the
thyroid isthmus. We then retract the thyroid lobe medially
using Allis clamps and use the LigaSure™ to divide the lower
and upper pole blood vessels. We believe that this change in
technique facilitates dissection of the thyroid lobes and helps
to reduce operating time. We have also found that this tech-
nique results in a decreased requirement for lateral skin
retraction; the reduction in incision length in the LigaSure™
group is probably a result of this decreased need for lateral
retraction.
This study was a retrospective, unblinded review of one
surgeon’s experience. In addition, the time periods for the two
study groups were different. The standard vessel ligation group
underwent thyroidectomy between 1997 and 2001, while the
Table 2. Comparison of operating time and incision length
Standard ligation LigaSure™
Operating time, hr 3.6 ( 0.1 2.9 ( 0.1*
Lobectomy time, hr 2.7 ( 0.1 2.2 ( 0.1*
Total thyroidectomy time, hr 4.1 ( 0.1 3.2 ( 0.1*
Incision length, cm 6.2 ( 0.1 5.7 ( 0.1*
*p < 0.05.
Table 3. Comparison of postoperative complications and
hospital stay
Standard ligation LigaSure™
Transient complications, n (%) 15 (15.2) 12 (8.9)
Permanent complications
   (RLN/SLN injury), n (%)
12 (2.0) 11 (0.7)
Hospital stay, d 1.2 ( 0.1 1.1 ( 0.03
RLN = recurrent laryngeal nerve; SLN = superior laryngeal nerve.
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LigaSure™ group underwent thyroidectomy between 2001
and 2003. We did not control for the factor of surgeon experi-
ence in our analysis of these two groups. It is possible that the
reductions in operating time seen in the later time period are
actually a result of increased surgeon experience rather than
use of the LigaSure™. However, at the time of commencement
of the first study period (1997), the surgeon had already been
in practice for 9 years and had performed more than 100 thy-
roidectomies. We believe that by this time, the surgeon had
already passed the steep portion of the learning curve and was
performing thyroidectomies in an efficient and safe manner.
In order to compare the use of standard vessel ligation and
LigaSure™ for thyroidectomy in a more rigorous fashion, we
have designed a multicentre randomized prospective trial.
This trial will preoperatively randomize patients undergoing
first-time thyroidectomy to either standard vessel ligation
using ties and sutures or vessel ligation using the LigaSure™.
In addition to comparing patient demographics, clinical
profiles, operating time, incision length, hospitalization and
complications, we would also like to determine whether the
thermal energy transferred during LigaSure™ use has any
effect on postoperative pain and/or nausea. These factors
could be studied by measuring medication requirements fol-
lowing operation.
Conclusion
In our retrospective review of our experience over the
past decade, patients undergoing thyroidectomy using the
LigaSure™ had reduced operating times and similar rates of
complications compared with patients undergoing thyroid-
ectomy using standard vessel ligation.
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